Home / Health / $30M Donation Fuels Groundbreaking Medical Research in Edmonton

$30M Donation Fuels Groundbreaking Medical Research in Edmonton

Summary

  • $30M donation in 2012 by Donald Kaye enables annual Kaye Competition
  • 45 research and clinical teams awarded over $7M since 2017
  • 2024 recipients focus on cancer, prostate cancer, and heart failure treatments
$30M Donation Fuels Groundbreaking Medical Research in Edmonton

In July 2025, the University Hospital Foundation in Edmonton, Alberta, announced the recipients of the 2024 Kaye Competition. The annual competition, a partnership between the Foundation and the University of Alberta Hospital, is funded by a $30 million donation made in 2012 by the late local philanthropist and businessman, Donald Kaye.

Since its inception in 2017, the Kaye Competition has awarded over $7 million to 45 research and clinical teams who are using innovative approaches, new partnerships, and bold ideas to advance patient care. The 2024 recipients are working on projects related to cancer, prostate cancer, and heart failure treatments, including the development of a point-of-care cancer treatment, the use of a new imaging technique to improve prostate cancer diagnosis, and the study of ketone therapy's impact on heart failure symptoms.

"Congratulations to the 2024 Kaye Competition recipients! We are proud to support their innovative projects and look forward to seeing the impact they will have on their patients and the future of health," said Dr. Jodi L. Abbott, President and CEO of the University Hospital Foundation.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

The Kaye Competition is an annual partnership between the University Hospital Foundation and the University of Alberta Hospital that funds research and quality improvement projects by local healthcare professionals to advance patient care.
The Kaye Competition has awarded over $7 million to 45 research and clinical teams since its inception in 2017.
The 2024 Kaye Competition recipients are working on projects related to cancer, prostate cancer, and heart failure treatments, including a new cancer treatment, improved prostate cancer diagnosis, and the study of ketone therapy for heart failure.

Read more news on